Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2009
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263402 Growth Differentiation Factor-11
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721269A1 Compounds and methods for altering bone growth
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1479300B1 Amino acid powder and process for producing the same
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009CN101563320A [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
10/21/2009CN101563088A Novel use of inhibitors of soluble epoxide hydrolase
10/21/2009CN101560268A Cs-4 fermentation mycelium polysaccharide and preparation method and applications thereof
10/21/2009CN101560253A Method for the crystallization of human serum albumin
10/21/2009CN101560178A Polysubstituted indoline compound, preparation method and medical application thereof
10/21/2009CN101559217A Oral administration route of 7P peptide and application thereof to prevention or treatment of nephritis
10/21/2009CN101559216A Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof
10/21/2009CN101559190A Oral Yiniao Kangfu capsule for curing nocturia and preparation method thereof
10/21/2009CN101559189A Oral Qianlie Kangfu capsule for curing acute prostatitis, chronic prostatitis and prostate hyperplasia and preparation method thereof
10/21/2009CN101559178A Medicated thread for curing acute nephritis, chronic nephritis and chronic renal failure and application thereof
10/21/2009CN101559177A Oral Shenyan Kangfu capsule for curing acute nephritis and chronic nephritis and preparation method thereof
10/21/2009CN101559154A Medicament for treating chronic prostatitis, and preparation method thereof
10/21/2009CN101559151A Oral Shenshuai Kangfu capsule for curing chronic renal failure and uremia and preparation method thereof
10/21/2009CN101559146A Oral Tonglin Paishi capsule for curing urinary calculi and preparation method thereof
10/21/2009CN101559144A Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof
10/21/2009CN101559113A Chinese materia medica preparation for treating chronic renal insufficiency and preparation method thereof
10/21/2009CN101559080A Medicament for treating uremia, and preparation method thereof
10/21/2009CN101559038A Solid lipid nanoparticles of finasteride and preparation method thereof
10/21/2009CN101558868A Health care food used for kidney deficiency
10/21/2009CN100551403C Medicine for treating chronic nephritis and its preparing process
10/21/2009CN100551379C Application of centella triterpenes in the preparing of medicine for preventing and curing kidney fibrosis
10/20/2009US7605173 Pharmaceutical liquid composition containing pyridone derivative
10/20/2009CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/15/2009WO2009126513A1 Colchicine solid complex; methods of making; and methods of use thereof
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258830 Diagnostic and therapeutic uses of gelsolin in renal failure
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108268A1 Extract of American cranberry and use thereof.
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN101557826A Therapeutic agent for urinary tract disease
10/14/2009CN101555235A Manufacture process of piperazine ferulate
10/14/2009CN101554234A Extract of American cranberry and use thereof
10/14/2009CN101554210A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
10/14/2009CN100549005C Optically active dihydropyridine derivative
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548310C Use of water soluble vitamin medicine in preparing medicine for prostate hyperplasia
10/14/2009CN100548297C Slow release drop pills comprising toraesmide active ingredient and method for preparing same
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601534 Maintaining a non-differentiated state of human stem cells, while allowing cell division of said human stem cells
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2264552C Method of using tetracycline compounds for inhibition of nitric oxide production
10/09/2009CA2659498A1 American cranberry extract and use
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122400A1 Phosphate binding polymers
10/08/2009WO2009121959A1 Use of glycosaminoglycan for restoring glycocalyx
10/08/2009WO2009121929A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder.
10/08/2009WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009WO2008062437A3 Process for the preparation of sevelamer hydrochloride and formulation thereof
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253705 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009US20090253665 Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitor
10/08/2009US20090253652 Phosphate-binding chitosan and uses thereof
10/08/2009CA2720410A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720306A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/07/2009EP2107050A1 Lipoxin compounds
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106792A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1311249B1 Set of transdermal therapeutic systems
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009CN101553491A Quinoxaline derivative
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 562